Found 11 matching trials
The Safety and Preliminary Tolerability of Lyophilized Lucinactant in Adults With Coronavirus Disease 2019 (COVID-19)
PHASE2This is a multicenter, single-treatment study. Subjects will consist of adu...
Location
University California San Diego - Jacobs Medical Center
The Safety and Efficacy of Lucinactant for Inhalation in Premature Neonates 26 to 32 Weeks Gestational Age
PHASE2The primary objective of this study is to evaluate the safety and efficacy ...
Location
University of Alabama at Birmingham
Feasibility Study of Aerosolized Surfaxin in the Prevention of Respiratory Distress Syndrome (RDS) in Premature Infants
PHASE2To evaluate the feasibility, safety and tolerability of aerosolized lucinac...
Location
University of California, San Diego Medical Center - Hillcrest
Trial To Assess The Safety And Tolerability Of Lucinactant For Inhalation In Preterm Neonates 26 to 28 Weeks PMA
PHASE2This study is to evaluate the safety and tolerability of lucinactant for in...
Location
Loma Linda University Medical Center
KL₄Surfactant Treatment in Patients With ARDS
PHASE2Lung wash with KL₄Surfactant of individual lung segments using a bronchosco...
Location
Discovery Laboratories, Inc.
SURFAXIN® Treatment for Prevention of Bronchopulmonary Dysplasia (BPD) in Very Low Birth Weight (VLBW) Infants.
PHASE2SURFAXIN® (lucinactant) treatment will be examined in very low birth weight...
Location
Discovery Laboratories, Inc.
Trial to Assess the Safety and Tolerability of Lucinactant for Inhalation in Premature Neonates
PHASE2The primary objective of this study is to evaluate the safety and tolerabil...
Location
University of Alabama at Birmingham
Phase III Randomized Study of Lucinactant in Full Term Newborn Infants With Meconium Aspiration Syndrome
PHASE3OBJECTIVES:
Evaluate the safety and efficacy of lucinactant administered b...
Location
Discovery Laboratories, Inc.
Effect of Lucinactant on Mucus Clearance in Cystic Fibrosis Lung Disease
PHASE2Mucus clearance is impaired in cystic fibrosis. Inhaled surfactants may red...
Location
University of North Carolina
A Safety and Efficacy Study of Lucinactant for Inhalation in Preterm Neonates 26 to 32 Weeks Gestational Age
PHASE2This study is to evaluate the safety and efficacy of lucinactant for inhala...
Location
Szpital Specjalistyczny nr 2 w Bytomiu Oddzial Noworodkow Blok Va